Whole-exome and ultradeep sequencing of gallbladder cancer revealed a panel of genes with nonsilent mutations, including TP53, KRAS and ERBB signaling components (EGFR, ERBB2, ERBB3, and ERBB4 and their downstream genes) [1]. Here, ERBB3 is linked to gallbladder cancer.